O	O	O	0	11	Cooperation	Cooperation	B-NP	NN	O	10	SUB	O
O	O	O	12	19	between	between	B-PP	IN	O	1	NMOD	O
T8	B-Entity	B-Entity	20	24	core	core	B-NP	NN	B-protein	5	NMOD	B-protein
T8	I-Entity	I-Entity	25	32	binding	binding	I-NP	NN	I-protein	5	NMOD	I-protein
T8	I-Entity	I-Entity	33	39	factor	factor	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	40	43	and	and	O	CC	O	9	NMOD	O
T9	B-Entity	B-Entity	44	52	adjacent	adjacent	B-NP	JJ	B-DNA	9	NMOD	B-DNA
T9	I-Entity	I-Entity	53	61	promoter	promoter	I-NP	NN	I-DNA	9	NMOD	I-DNA
T9	I-Entity	I-Entity	62	70	elements	element	I-NP	NNS	I-DNA	2	PMOD	I-DNA
O	O	O	71	82	contributes	contribute	B-VP	VBZ	O	0	ROOT	O
O	O	O	83	85	to	to	B-PP	TO	O	10	VMOD	O
O	O	O	86	89	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	90	96	tissue	tissue	I-NP	NN	O	16	NMOD	O
O	O	O	96	97	-	-	B-NP	HYPH	O	16	NMOD	O
O	O	O	97	105	specific	specific	I-NP	JJ	O	16	NMOD	O
O	O	O	106	116	expression	expression	I-NP	NN	O	11	PMOD	O
O	O	O	117	119	of	of	B-PP	IN	O	16	NMOD	O
T1	B-Protein	B-Protein	120	131	interleukin	interleukin	B-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	I-Protein	131	132	-	-	B-NP	HYPH	I-protein	17	PMOD	I-protein
T1	I-Protein	I-Protein	132	133	3	3	I-NP	CD	I-protein	19	NMOD	I-protein
O	O	O	133	134	.	.	O	.	O	10	P	O

O	O	O	136	142	Tissue	Tissue	B-NP	NN	O	4	NMOD	O
O	O	O	142	143	-	-	I-NP	HYPH	O	1	P	O
O	O	O	143	151	specific	specific	I-NP	JJ	O	4	NMOD	O
O	O	O	152	162	expression	expression	I-NP	NN	O	14	SUB	O
O	O	O	163	165	of	of	B-PP	IN	O	4	NMOD	O
T2	B-Protein	B-Protein	166	177	interleukin	interleukin	B-NP	NN	B-protein	5	PMOD	B-protein
T2	I-Protein	I-Protein	177	178	-	-	B-NP	HYPH	O	6	P	O
T2	I-Protein	I-Protein	178	179	3	3	I-NP	CD	O	6	NMOD	O
O	O	O	180	181	(	(	O	(	O	13	DEP	O
T3	B-Protein	B-Protein	181	183	IL	IL	B-NP	NN	B-protein	13	DEP	B-protein
T3	I-Protein	I-Protein	183	184	-	-	B-ADJP	HYPH	I-protein	12	DEP	I-protein
T3	I-Protein	I-Protein	184	185	3	3	B-LST	LS	I-protein	10	NMOD	I-protein
O	O	O	185	186	)	)	O	)	O	6	NMOD	O
O	O	O	187	189	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	190	198	mediated	mediate	I-VP	VBN	O	14	VC	O
O	O	O	199	202	via	via	B-PP	IN	O	15	VMOD	O
T10	B-Entity	B-Entity	203	206	cis	cis	B-NP	NN	B-DNA	20	NMOD	B-DNA
T10	I-Entity	I-Entity	206	207	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T10	I-Entity	I-Entity	207	213	acting	act	I-NP	VBG	I-DNA	20	NMOD	I-DNA
T10	I-Entity	I-Entity	214	222	elements	element	I-NP	NNS	I-DNA	16	PMOD	I-DNA
O	O	O	223	230	located	located	B-ADJP	JJ	O	20	NMOD	O
O	O	O	231	237	within	within	B-PP	IN	O	21	AMOD	O
O	O	O	238	241	315	315	B-NP	CD	O	25	NMOD	O
O	O	O	242	246	base	base	I-NP	NN	O	25	NMOD	O
O	O	O	247	252	pairs	pair	I-NP	NNS	O	22	PMOD	O
O	O	O	253	255	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	256	259	the	the	B-NP	DT	O	29	NMOD	O
T11	B-Entity	B-Entity	260	273	transcription	transcription	I-NP	NN	O	29	NMOD	O
T11	I-Entity	I-Entity	274	279	start	start	I-NP	NN	O	26	PMOD	O
O	O	O	279	280	.	.	O	.	O	14	P	O

O	O	O	281	285	This	This	B-NP	DT	O	2	SUB	O
O	O	O	286	288	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	289	297	achieved	achieve	I-VP	VBN	O	2	VC	O
O	O	O	298	300	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	301	305	part	part	B-NP	NN	O	4	PMOD	O
O	O	O	306	313	through	through	B-PP	IN	O	3	VMOD	O
O	O	O	314	317	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	318	326	positive	positive	I-NP	JJ	O	9	NMOD	O
O	O	O	327	337	activities	activity	I-NP	NNS	O	6	PMOD	O
O	O	O	338	340	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	341	344	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	345	347	AP	AP	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	347	348	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
O	O	O	348	349	1	1	I-NP	CD	I-protein	16	NMOD	I-protein
O	O	O	350	353	and	and	I-NP	CC	O	16	NMOD	O
O	O	O	354	357	Elf	Elf	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	357	358	-	-	O	HYPH	O	19	NMOD	O
O	O	O	358	359	1	1	B-NP	CD	B-DNA	19	NMOD	B-DNA
T12	B-Entity	B-Entity	360	365	sites	site	I-NP	NNS	I-DNA	10	PMOD	I-DNA
O	O	O	366	368	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	369	372	the	the	B-NP	DT	O	25	NMOD	O
T4	B-Protein	B-Protein	373	375	IL	IL	I-NP	NN	B-DNA	25	NMOD	B-DNA
T4	I-Protein	I-Protein	375	376	-	-	B-NP	HYPH	I-DNA	25	NMOD	I-DNA
T4	I-Protein	I-Protein	376	377	3	3	I-NP	CD	I-DNA	25	NMOD	I-DNA
T13	B-Entity	B-Entity	378	386	promoter	promoter	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	O	386	387	.	.	O	.	O	2	P	O

O	O	O	388	391	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	392	404	contribution	contribution	I-NP	NN	O	8	NMOD	O
O	O	O	405	407	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	408	409	T	T	B-NP	NN	B-cell_type	5	NMOD	B-cell_type
O	O	O	410	414	cell	cell	I-NP	NN	I-cell_type	3	PMOD	I-cell_type
O	O	O	414	415	-	-	B-NP	HYPH	O	8	NMOD	O
O	O	O	415	423	specific	specific	I-NP	JJ	O	8	NMOD	O
O	O	O	424	434	expression	expression	I-NP	NN	O	13	SUB	O
O	O	O	435	437	by	by	B-PP	IN	O	8	NMOD	O
O	O	O	438	443	other	other	B-NP	JJ	O	12	NMOD	O
T14	B-Entity	B-Entity	444	452	promoter	promoter	I-NP	NN	B-DNA	12	NMOD	B-DNA
T14	I-Entity	I-Entity	453	458	sites	site	I-NP	NNS	I-DNA	9	PMOD	I-DNA
O	O	O	459	462	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	463	471	assessed	assess	I-VP	VBN	O	13	VC	O
O	O	O	472	474	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	475	476	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	477	486	transient	transient	I-NP	JJ	O	19	NMOD	O
O	O	O	487	497	expression	expression	I-NP	NN	O	19	NMOD	O
O	O	O	498	503	assay	assay	I-NP	NN	O	15	PMOD	O
O	O	O	504	508	with	with	B-PP	IN	O	19	NMOD	O
T5	B-Protein	B-Protein	509	511	IL	IL	B-NP	NN	B-DNA	25	NMOD	B-DNA
T5	I-Protein	I-Protein	511	512	-	-	B-NP	HYPH	I-DNA	25	NMOD	I-DNA
T5	I-Protein	I-Protein	512	513	3	3	I-NP	CD	I-DNA	25	NMOD	I-DNA
O	O	O	514	522	promoter	promoter	I-NP	NN	I-DNA	25	NMOD	I-DNA
O	O	O	523	533	constructs	construct	I-NP	NNS	I-DNA	20	PMOD	I-DNA
O	O	O	534	540	linked	link	B-VP	VBN	O	25	NMOD	O
O	O	O	541	543	to	to	B-PP	TO	O	26	VMOD	O
O	O	O	544	545	a	a	B-NP	DT	O	30	NMOD	O
T15	B-Entity	B-Entity	546	556	luciferase	luciferase	I-NP	NN	B-DNA	30	NMOD	B-DNA
T15	I-Entity	I-Entity	557	561	gene	gene	I-NP	NN	I-DNA	27	PMOD	I-DNA
O	O	O	561	562	,	,	O	,	O	14	P	O
O	O	O	563	571	focusing	focus	B-VP	VBG	O	14	VMOD	O
O	O	O	572	581	initially	initially	B-ADVP	RB	O	32	VMOD	O
O	O	O	582	584	on	on	B-PP	IN	O	32	VMOD	O
O	O	O	585	588	the	the	B-NP	DT	O	42	NMOD	O
T16,T17	B-Entity,B-Entity	B-Entity,B-Entity	589	593	core	core	I-NP	NN	B-DNA	42	NMOD	B-DNA
T16,T17	I-Entity,I-Entity	I-Entity,I-Entity	594	601	binding	binding	I-NP	NN	I-DNA	42	NMOD	I-DNA
T16,T17	I-Entity,I-Entity	I-Entity,I-Entity	602	608	factor	factor	I-NP	NN	I-DNA	42	NMOD	I-DNA
T16	I-Entity	I-Entity	609	610	(	(	O	(	I-DNA	42	NMOD	I-DNA
T16,T18	I-Entity,B-Entity	I-Entity,B-Entity	610	613	CBF	CBF	B-NP	NN	I-DNA	42	NMOD	I-DNA
T16	I-Entity	I-Entity	613	614	)	)	O	)	I-DNA	42	NMOD	I-DNA
T16	I-Entity	I-Entity	615	619	site	site	B-NP	NN	I-DNA	34	PMOD	I-DNA
O	O	O	619	620	,	,	O	,	O	42	P	O
O	O	O	621	626	which	which	B-NP	WDT	O	42	NMOD	O
O	O	O	627	629	is	be	B-VP	VBZ	O	44	SBAR	O
O	O	O	630	641	footprinted	footprinte	I-VP	VBN	O	45	VC	O
O	O	O	642	644	in	in	B-ADVP	FW	O	46	VMOD	O
O	O	O	645	649	vivo	vivo	I-ADVP	FW	O	47	AMOD	O
O	O	O	650	654	upon	upon	B-PP	IN	O	46	VMOD	O
O	O	O	655	656	T	T	B-NP	NN	O	52	NMOD	O
O	O	O	657	661	cell	cell	I-NP	NN	O	52	NMOD	O
O	O	O	662	672	activation	activation	I-NP	NN	O	49	PMOD	O
O	O	O	672	673	.	.	O	.	O	13	P	O

O	O	O	674	682	Activity	Activity	B-NP	NN	O	6	SUB	O
O	O	O	683	685	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	686	689	the	the	B-NP	DT	O	5	NMOD	O
T19,T20	B-Entity,B-Entity	B-Entity,B-Entity	690	693	CBF	CBF	I-NP	NN	B-DNA	5	NMOD	B-DNA
T19	I-Entity	I-Entity	694	698	site	site	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	699	701	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	702	707	shown	show	I-VP	VBN	O	6	VC	O
O	O	O	708	710	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	711	713	be	be	I-VP	VB	O	7	VMOD	O
O	O	O	714	724	critically	critically	B-ADJP	RB	O	11	AMOD	O
O	O	O	725	734	dependent	dependent	I-ADJP	JJ	O	9	PRD	O
O	O	O	735	737	on	on	B-PP	IN	O	11	AMOD	O
O	O	O	738	741	the	the	B-NP	DT	O	12	PMOD	O
T21	B-Entity	B-Entity	742	750	adjacent	adjacent	I-NP	JJ	B-DNA	18	NMOD	B-DNA
T21	I-Entity	I-Entity	751	760	activator	activator	I-NP	NN	I-DNA	18	NMOD	I-DNA
T21	I-Entity	I-Entity	761	765	site	site	I-NP	NN	I-DNA	18	NMOD	I-DNA
T21	I-Entity	I-Entity	766	769	Act	Act	I-NP	NN	I-DNA	18	NMOD	I-DNA
T21	I-Entity	I-Entity	769	770	-	-	B-NP	HYPH	I-DNA	13	NMOD	I-DNA
T21	I-Entity	I-Entity	770	771	1	1	I-NP	CD	I-DNA	18	NMOD	I-DNA
O	O	O	771	772	.	.	O	.	O	6	P	O

O	O	O	773	781	Together	Together	B-ADVP	RB	O	9	VMOD	O
O	O	O	782	785	the	the	B-NP	DT	O	8	NMOD	O
T22	B-Entity	B-Entity	786	789	Act	Act	I-NP	NN	B-protein	8	NMOD	B-protein
T22	I-Entity	I-Entity	789	790	-	-	B-NP	HYPH	I-protein	3	NMOD	I-protein
T22	I-Entity	I-Entity	790	791	1	1	I-NP	CD	I-protein	4	NMOD	I-protein
O	O	O	792	795	and	and	I-NP	CC	O	8	NMOD	O
T23	B-Entity	B-Entity	796	799	CBF	CBF	I-NP	NN	B-DNA	8	NMOD	B-DNA
T23	I-Entity	I-Entity	800	805	sites	site	I-NP	NNS	I-DNA	9	SUB	I-DNA
O	O	O	806	810	form	form	B-VP	VBP	O	0	ROOT	O
O	O	O	811	812	a	a	B-NP	DT	O	12	NMOD	O
T24	B-Entity	B-Entity	813	823	functional	functional	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T24	I-Entity	I-Entity	824	828	unit	unit	I-NP	NN	I-DNA	9	OBJ	I-DNA
O	O	O	829	830	(	(	O	(	O	16	DEP	O
T25	B-Entity	B-Entity	830	832	AC	AC	B-NP	NN	B-DNA	15	NMOD	B-DNA
T25	I-Entity	I-Entity	833	837	unit	unit	I-NP	NN	I-DNA	16	DEP	I-DNA
O	O	O	837	838	)	)	O	)	O	12	NMOD	O
O	O	O	839	843	with	with	B-PP	IN	O	12	NMOD	O
O	O	O	844	848	dual	dual	B-NP	JJ	O	19	NMOD	O
O	O	O	849	857	activity	activity	I-NP	NN	O	17	PMOD	O
O	O	O	857	858	.	.	O	.	O	9	P	O

O	O	O	859	862	The	The	B-NP	DT	O	3	NMOD	O
T26	B-Entity	B-Entity	863	865	AC	AC	I-NP	NN	B-DNA	3	NMOD	B-DNA
T26	I-Entity	I-Entity	866	870	unit	unit	I-NP	NN	I-DNA	4	SUB	I-DNA
O	O	O	871	873	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	874	886	demonstrated	demonstrate	I-VP	VBN	O	4	VC	O
O	O	O	887	889	to	to	I-VP	TO	O	9	VMOD	O
O	O	O	890	897	enhance	enhance	I-VP	VB	O	9	NMOD	O
O	O	O	898	903	basal	basal	B-NP	JJ	O	9	NMOD	O
O	O	O	904	912	activity	activity	I-NP	NN	O	5	VMOD	O
O	O	O	913	915	of	of	B-PP	IN	O	9	NMOD	O
T27	B-Entity	B-Entity	916	925	promoters	promoter	B-NP	NNS	B-DNA	10	PMOD	B-DNA
O	O	O	926	930	both	both	B-PP	CC	O	13	PMOD	O
O	O	O	931	933	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	934	945	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	17	NMOD	B-cell_type
O	O	O	946	949	and	and	O	CC	O	17	NMOD	O
O	O	O	950	951	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	952	957	cells	cell	B-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	957	958	.	.	O	.	O	4	P	O

O	O	O	959	963	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	964	972	activity	activity	I-NP	NN	O	3	SUB	O
O	O	O	973	975	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	976	983	further	further	B-ADJP	RBR	O	5	AMOD	O
O	O	O	984	993	inducible	inducible	I-ADJP	JJ	O	3	PRD	O
O	O	O	994	996	in	in	B-PP	IN	O	5	AMOD	O
O	O	O	997	1006	activated	activate	B-NP	VBN	B-cell_type	9	NMOD	B-cell_type
O	O	O	1007	1008	T	T	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	1009	1014	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	1014	1015	,	,	B-PP	,	O	5	P	O
O	O	O	1016	1019	but	but	I-PP	CC	O	5	PMOD	O
O	O	O	1020	1023	not	not	B-PP	RB	O	11	DEP	O
O	O	O	1024	1026	in	in	I-PP	IN	O	5	AMOD	O
O	O	O	1027	1038	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	13	PMOD	B-cell_type
O	O	O	1038	1039	.	.	O	.	O	3	P	O

O	O	O	1040	1042	In	In	B-PP	IN	O	12	VMOD	O
O	O	O	1043	1051	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	1052	1054	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	1055	1058	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1059	1066	already	already	I-NP	RB	O	6	AMOD	O
O	O	O	1067	1077	identified	identify	I-NP	VBN	O	9	NMOD	O
T28	B-Entity	B-Entity	1078	1081	NIP	NIP	I-NP	NN	B-DNA	9	NMOD	B-DNA
T28	I-Entity	I-Entity	1082	1091	repressor	repressor	I-NP	NN	I-DNA	9	NMOD	I-DNA
T28	I-Entity	I-Entity	1092	1096	site	site	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	1096	1097	,	,	O	,	O	12	P	O
O	O	O	1098	1106	evidence	evidence	B-NP	NN	O	12	SUB	O
O	O	O	1107	1109	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1110	1119	presented	present	I-VP	VBN	O	12	VC	O
O	O	O	1120	1123	for	for	B-PP	IN	O	13	VMOD	O
O	O	O	1124	1125	a	a	B-NP	DT	O	18	NMOD	O
T29	B-Entity	B-Entity	1126	1132	second	second	I-NP	JJ	B-DNA	18	NMOD	B-DNA
T29	I-Entity	I-Entity	1133	1142	repressor	repressor	I-NP	NN	I-DNA	18	NMOD	I-DNA
T29	I-Entity	I-Entity	1143	1149	region	region	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	1150	1154	that	that	B-NP	WDT	O	18	NMOD	O
O	O	O	1155	1164	restricts	restrict	B-VP	VBZ	O	19	SBAR	O
T30	B-Entity	B-Entity	1165	1173	promoter	promoter	B-NP	NN	O	22	NMOD	O
O	O	O	1174	1182	activity	activity	I-NP	NN	O	20	OBJ	O
O	O	O	1183	1185	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	1186	1197	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	23	PMOD	B-cell_type
O	O	O	1197	1198	.	.	O	.	O	12	P	O

O	O	O	1199	1206	Finally	Finally	B-ADVP	RB	O	8	VMOD	O
O	O	O	1206	1207	,	,	O	,	O	8	P	O
O	O	O	1208	1209	a	a	B-NP	DT	O	4	NMOD	O
O	O	O	1210	1215	novel	novel	I-NP	JJ	O	8	SUB	O
T31	B-Entity	B-Entity	1216	1224	positive	positive	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T31	I-Entity	I-Entity	1225	1235	regulatory	regulatory	I-NP	JJ	I-DNA	7	NMOD	I-DNA
T31	I-Entity	I-Entity	1236	1243	element	element	I-NP	NN	I-DNA	4	NMOD	I-DNA
O	O	O	1244	1247	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	1248	1252	been	be	I-VP	VBN	O	8	VC	O
O	O	O	1253	1259	mapped	map	I-VP	VBN	O	9	VC	O
O	O	O	1260	1262	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1263	1266	the	the	B-NP	DT	O	16	NMOD	O
T6	B-Protein	B-Protein	1267	1269	IL	IL	I-NP	NN	B-DNA	16	NMOD	B-DNA
T6	I-Protein	I-Protein	1269	1270	-	-	B-NP	HYPH	I-DNA	16	NMOD	I-DNA
T6	I-Protein	I-Protein	1270	1271	3	3	I-NP	CD	I-DNA	16	NMOD	I-DNA
T32	B-Entity	B-Entity	1272	1280	promoter	promoter	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	O	1281	1288	between	between	B-PP	IN	O	16	NMOD	O
O	O	O	1289	1299	nucleotide	nucleotide	B-NP	NN	B-DNA	22	NMOD	B-DNA
O	O	O	1300	1301	-	-	B-NP	HYPH	I-DNA	18	NMOD	I-DNA
O	O	O	1301	1304	180	180	I-NP	CD	I-DNA	19	NMOD	I-DNA
O	O	O	1305	1308	and	and	O	CC	I-DNA	22	NMOD	I-DNA
O	O	O	1309	1310	-	-	O	SYM	I-DNA	17	PMOD	I-DNA
O	O	O	1310	1313	210	210	B-NP	CD	I-DNA	22	NMOD	I-DNA
O	O	O	1314	1318	that	that	B-NP	WDT	O	16	NMOD	O
O	O	O	1319	1324	leads	lead	B-VP	VBZ	O	24	SBAR	O
O	O	O	1325	1327	to	to	B-PP	TO	O	25	VMOD	O
O	O	O	1328	1337	increased	increase	B-NP	VBN	O	28	NMOD	O
O	O	O	1338	1348	expression	expression	I-NP	NN	O	26	PMOD	O
O	O	O	1349	1351	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	1352	1353	T	T	B-NP	NN	B-cell_type	31	NMOD	B-cell_type
O	O	O	1354	1359	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	I-cell_type
O	O	O	1359	1360	.	.	O	.	O	8	P	O

O	O	O	1361	1369	Together	Together	B-ADVP	RB	O	4	VMOD	O
O	O	O	1370	1375	these	these	B-NP	DT	O	3	NMOD	O
O	O	O	1376	1383	results	result	I-NP	NNS	O	4	SUB	O
O	O	O	1384	1395	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1396	1400	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	1401	1402	T	T	B-NP	NN	O	8	NMOD	O
O	O	O	1403	1407	cell	cell	I-NP	NN	O	8	NMOD	O
O	O	O	1408	1418	expression	expression	I-NP	NN	O	13	SUB	O
O	O	O	1419	1421	of	of	B-PP	IN	O	8	NMOD	O
T7	B-Protein	B-Protein	1422	1424	IL	IL	B-NP	NN	B-protein	11	NMOD	B-protein
T7	I-Protein	I-Protein	1424	1425	-	-	B-NP	HYPH	I-protein	9	PMOD	I-protein
T7	I-Protein	I-Protein	1425	1426	3	3	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	1427	1429	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	O	1430	1433	not	not	I-VP	RB	O	13	VMOD	O
O	O	O	1434	1443	specified	specify	I-VP	VBN	O	13	VC	O
O	O	O	1444	1446	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	1447	1450	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1451	1459	activity	activity	I-NP	NN	O	16	PMOD	O
O	O	O	1460	1462	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	1463	1464	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	1465	1471	single	single	I-NP	JJ	O	19	PMOD	O
T33	B-Entity	B-Entity	1472	1478	tissue	tissue	I-NP	NN	B-DNA	21	NMOD	B-DNA
T33	I-Entity	I-Entity	1478	1479	-	-	B-NP	HYPH	I-DNA	21	NMOD	I-DNA
T33	I-Entity	I-Entity	1479	1487	specific	specific	I-NP	JJ	I-DNA	25	NMOD	I-DNA
T33	I-Entity	I-Entity	1488	1495	element	element	I-NP	NN	I-DNA	21	NMOD	I-DNA
O	O	O	1495	1496	,	,	O	,	O	13	P	O
O	O	O	1497	1500	but	but	O	CC	O	13	VMOD	O
O	O	O	1501	1508	instead	instead	B-VP	RB	O	13	VMOD	O
O	O	O	1509	1517	involves	involve	I-VP	VBZ	O	13	VMOD	O
O	O	O	1518	1526	multiple	multiple	B-NP	JJ	O	32	NMOD	O
T34	B-Entity	B-Entity	1527	1538	interacting	interact	I-NP	VBG	B-DNA	32	NMOD	B-DNA
T34	I-Entity	I-Entity	1539	1547	elements	element	I-NP	NNS	I-DNA	29	OBJ	I-DNA
O	O	O	1548	1552	that	that	B-NP	WDT	O	32	NMOD	O
O	O	O	1553	1560	provide	provide	B-VP	VBP	O	33	SBAR	O
O	O	O	1561	1565	both	both	O	CC	O	38	NMOD	O
O	O	O	1566	1574	specific	specific	B-NP	JJ	O	38	NMOD	O
O	O	O	1575	1583	positive	positive	I-NP	JJ	O	38	NMOD	O
O	O	O	1584	1594	regulation	regulation	I-NP	NN	O	34	OBJ	O
O	O	O	1595	1597	in	in	B-PP	IN	O	38	NMOD	O
O	O	O	1598	1599	T	T	B-NP	NN	B-cell_type	41	NMOD	B-cell_type
O	O	O	1600	1605	cells	cell	I-NP	NNS	I-cell_type	45	NMOD	I-cell_type
O	O	O	1606	1609	and	and	O	CC	O	45	NMOD	O
O	O	O	1610	1618	specific	specific	B-NP	JJ	O	45	NMOD	O
O	O	O	1619	1627	negative	negative	I-NP	JJ	O	45	NMOD	O
O	O	O	1628	1638	regulation	regulation	I-NP	NN	O	39	PMOD	O
O	O	O	1639	1641	in	in	B-PP	IN	O	45	NMOD	O
O	O	O	1642	1653	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	46	PMOD	B-cell_type
O	O	O	1653	1654	.	.	O	.	O	4	P	O
